İlko İlaç, which serves in the pharmaceuticals industry, operates under Selçuklu Holding. Selçuklu Holding, founded by Mustafa Öncel, is a company that has carried out various projects and works and has a long experience. The founder Mustafa Öncel first started their career in the pharmaceutical industry by opening a pharmacy in the 1960s. Later, to grow the business more, İlko İlaç joined the company’s organization in 2012.
Having more than 50 years of experience in the pharmaceutical industry, İlko İlaç aims to provide its customers with the highest level of service and to satisfy them. Ilko Pharmaceuticals is one of the leading companies in the pharmaceutical industry with its high-quality and wide product range, with a product portfolio centered on advanced technology that covers all important treatment areas.
Ilko İlaç, which has products in many fields such as cardiology, central nervous system, rare diseases, and acute products, has two main product categories as prescription products and consumer health products. Besides, İlko İlaç attaches great importance to activities in the field of consumer health. The company also puts great emphasis on R&D studies and it has its own R&D center.
The company continues to work based on advanced technology and aims to continuously increase its product quality at its research center İLKO ARGEM. It also bears the distinction by having various certificates such as ISO 14001, TS EN ISO 13485, and many others among its competitors. İlko İlaç, which carries out licensing activities in more than 40 countries, contributes to the national economy by exporting to more than 25 countries today.
Certificates:ISO 14001:2015 – ENVIRONMENTAL MANAGEMENT SYSTEM, OHSAS 18001:2007 – OCCUPATIONAL HEALTH AND SAFETY MANAGEMENT, ISO 27001:2013 – INFORMATION SECURITY MANAGEMENT SYSTEM, BS 10012:2017 – PERSONAL INFORMATION MANAGEMENT, TS EN ISO 13485 – MEDICAL DEVICES QUALITY MANAGEMENT, MEDICINES AUTHORITY – MALTA EUROPE GMP,